CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
will evaluate the pharmacokinetics, safety and tolerability, and immunogenicity of ocrelizumab administered subcutaneously to participants with multiple...
Phase 1
Pittsburgh, Pennsylvania, United States and 19 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Pittsburgh, Pennsylvania, United States and 241 other locations
Clinical trials
Research sites
Resources
Legal